These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37786919)
41. Interventions targeted at oxidatively generated modifications of nucleic acids focused on urine and plasma markers. Larsen EL; Weimann A; Poulsen HE Free Radic Biol Med; 2019 Dec; 145():256-283. PubMed ID: 31563634 [TBL] [Abstract][Full Text] [Related]
42. The use of mass spectrometry in genomics. Meng Z; Simmons-Willis TA; Limbach PA Biomol Eng; 2004 Jan; 21(1):1-13. PubMed ID: 14715314 [TBL] [Abstract][Full Text] [Related]
43. Locked and unlocked nucleosides in functional nucleic acids. Doessing H; Vester B Molecules; 2011 May; 16(6):4511-26. PubMed ID: 21629180 [TBL] [Abstract][Full Text] [Related]
44. Quantification of Modified Nucleosides in the Context of NAIL-MS. Heiss M; Borland K; Yoluç Y; Kellner S Methods Mol Biol; 2021; 2298():279-306. PubMed ID: 34085252 [TBL] [Abstract][Full Text] [Related]
45. [Mass spectrometry of nucleic acids in molecular medicine]. Il'ina EN; Govorun VM Bioorg Khim; 2009; 35(2):149-64. PubMed ID: 19537166 [TBL] [Abstract][Full Text] [Related]
46. Nucleic Acid analysis by fourier transform ion cyclotron resonance mass spectrometry at the beginning of the twenty-first century. Frahm JL; Muddiman DC Curr Pharm Des; 2005; 11(20):2593-613. PubMed ID: 16101461 [TBL] [Abstract][Full Text] [Related]
47. Recent advances in therapeutic nucleic acids and their analytical methods. Talap J; Zhao J; Shen M; Song Z; Zhou H; Kang Y; Sun L; Yu L; Zeng S; Cai S J Pharm Biomed Anal; 2021 Nov; 206():114368. PubMed ID: 34571322 [TBL] [Abstract][Full Text] [Related]
48. Use of High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) to Quantify Modified Nucleosides. Rodell R; Tsao N; Ganguly A; Mosammaparast N Methods Mol Biol; 2022; 2444():125-140. PubMed ID: 35290635 [TBL] [Abstract][Full Text] [Related]
49. Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways. Deng Y; Wang Y; Li L; Miao EA; Liu P Front Immunol; 2022; 13():898724. PubMed ID: 35795661 [TBL] [Abstract][Full Text] [Related]
50. Not all 2',4'-bridged modifications stabilize DNA/RNA duplexes. Akita T; Tomita-Sudo E; Itoh S; Sakimoto N; Masuda T; Nakamura A; Onishi Y; Koizumi M; Kawakami J Nucleosides Nucleotides Nucleic Acids; 2024; 43(1):57-64. PubMed ID: 37424260 [TBL] [Abstract][Full Text] [Related]
51. The current perspective and opportunities of small nucleic acid-based therapeutics. Chen Y; Li Y; Li C; Zhang D; Liu Y; Zhang J; Guan S; Ding X; Xiao Q Drug Dev Res; 2024 Apr; 85(2):e22164. PubMed ID: 38411296 [TBL] [Abstract][Full Text] [Related]
52. Tellurium-Modified Nucleosides, Nucleotides, and Nucleic Acids with Potential Applications. Chen C; Huang Z Molecules; 2022 Dec; 27(23):. PubMed ID: 36500495 [TBL] [Abstract][Full Text] [Related]
53. MALDI mass spectrometry for nucleic acid analysis. Gao X; Tan BH; Sugrue RJ; Tang K Top Curr Chem; 2013; 331():55-77. PubMed ID: 23019094 [TBL] [Abstract][Full Text] [Related]